Effects of special infant formulas on growth and digestion in healthy babies
Official title: Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants: a Double-blind, Randomized, Controlled, Multi-arm Trial
Run by Société des Produits Nestlé (SPN) · NCT05868408 · Data updated 2026-11-12
This study tests how special baby formulas made from whey protein affect the growth and tummy comfort of healthy infants.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 0 Days to 28 Days |
| Sex | All |
| Enrollment | 234 (estimated) |
| Sponsor | Société des Produits Nestlé (SPN) Industry-sponsored |
| Locations | 5 sites (Cavite City and 4 other locations) |
| Status | Recruiting |
| Started | August 17, 2023 |
| Main results expected | December 2027 |
| Study ends | June 2028 |
| Registry record updated | July 15, 2026 |
| Trial ID | NCT05868408 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy term infants aged 28 days or younger who are fully formula-fed and meet specific weight and gestational age criteria.
✕Probably not a fit
Infants with chronic illnesses, congenital abnormalities, or maternal conditions affecting growth may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates how partially hydrolyzed, whey-based infant formulas impact growth and gastrointestinal tolerance in healthy term infants. The research involves administering different formulas to assess their effects on infant development and comfort. Eligible infants will be monitored for growth metrics and any gastrointestinal issues over a specified period. The study aims to provide insights into the nutritional needs of infants who are formula-fed.
Why it matters
Potential benefit: If successful, this study could lead to improved infant growth and digestive health through optimized formula options.
How similar studies have gone: Other studies have shown positive outcomes with similar approaches in infant nutrition, suggesting potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Written informed consent has been obtained from at least one parent (or other legally acceptable representative \[LAR\]), if applicable) 2. Infant gestational age ≥37 completed weeks 3. Infant birth weight of ≥2.5 kg and ≤4.5 kg 4. Singleton birth 5. For Saudi: Infant postnatal age ≤28 days (date of birth = day 0); For Philippines: Infant postnatal age ≥ 14 days and ≤ 28 days (date of birth = day 0). 6. Mother has previously decided to fully formula-feed, and infant is no longer breastfeeding or receiving breast milk 7. Infant's parent(s)/LAR is of legal age of majority, must understand the informed consent form and other relevant study documents, and is willing and able to fulfill the requirements of the study protocol Exclusion Criteria: 1. Chronic infectious, metabolic, genetic illness or other disease, including any condition that impacts feeding or growth 2. Major congenital or chromosomal abnormality known to affect growth (e.g., congenital heart disease, cystic fibrosis) 3. Maternal medical conditions known to affect infant growth (e.g., untreated preeclampsia or gestational diabetes) 4. Infants with special dietary needs other than standard infant formula 5. Infants with known (or symptoms suggestive of) cow's milk protein intolerance/allergy, or lactose intolerance or severe food allergies that impact diet 6. Child has other medical or psychiatric condition that, in the judgement of the investigator, would make the child inappropriate for entry into the study 7. Currently participating or having participated in another interventional clinical trial prior to enrollment
Where it's running
-
Biomedical Research Institute
Cavite City, Philippines Recruiting -
Biomedical Research Institute
Las Piñas, Philippines Recruiting -
National Guard Hospital
Jeddah, Saudi Arabia Active not recruiting -
King Faisal Specialist Hospital and Research Center
Riyadh, Saudi Arabia Completed -
National Guard Hospital
Riyadh, Saudi Arabia Completed
Study contacts
- Study coordinator: Qiaoji Li
- Email: qiaoji.li@rd.nestle.com
- Phone: +861087419794
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Does a daily kids multivitamin support growth, immunity, energy, and focus in healthy children aged 3–12?
This study tests whether a daily Hiya Kids multivitamin improves perceived growth, immune health, energy, and focus in generally healthy children aged 3–12 over eight weeks.
-
Methyl-Donor Rich Diet in the Postpartum Period
Researchers will test whether a methyl-donor‑rich diet in the first weeks after birth helps reduce maternal depression and supports breastfeeding and infant growth.
-
How infants' brains track speech during the first year
This study will test whether 7–8 month-old babies' brain responses to speech predict their receptive and expressive language skills at about 18 months, comparing infants with and without a family history of language or learning problems.
-
Understanding early development in infants and toddlers
This project will try to describe cognitive, language, motor, social-emotional, and adaptive development in infants and toddlers aged 16 days to 42 months using a one-time developmental session and parent questionnaires.
-
Group postpartum and well-child care for mothers and babies
We will test whether group postpartum and well-child care for new mothers and their babies in Zomba District, Malawi leads to better maternal and infant health over the first year after birth compared with usual individual care.
-
BAM Index: measuring arm and hand behavior in infants and toddlers
This project tries a set of behavioral measurements to see if they can reliably describe arm, hand, and other developmental skills in infants and toddlers with and without perinatal stroke or hemiparetic cerebral palsy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.